A study by researchers working in Brazil shows that antimicrobial photodynamic therapy in which blue light targets annatto colorant is a feasible and effective option for treatment of halitosis in mouth-breathing children.
A catalyst for quality: FDA’s Voluntary Improvement Program saves time, improves process and enhances patient outcomes
The US Food and Drug Administration (FDA) recently announced its support of the Case for Quality Voluntary Improvement Program (VIP) through a final Guidance published in
November 13, 2023